2026-10-04
Sachem Capital Corp. 6.00% Note clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 30,808 +1.00%
S&P 7,723 +0.73%
GOLD $4,160 −0.06%
BTC $85,503 +0.87%
VIX 15.31 −6.59%
live tape · as of 05:02 UTC
The Screen
Sachem Capital Corp. 6.00% Note
SCCE · NYSE American · USD
Not yet scored24.72 USD
Screen close, 2026-09-18 · not a live quote
Last reviewed 17 days ago
Screened 2026-09-18 · the tape above runs as of 05:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 24.72 against the desk's fair-value range, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price24.72 USD
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Markdown24.72+0.0% to today
2026-09-12Read Accumulation24.75-0.1% to today
2026-08-12Read Markdown24.75-0.1% to today ✓
2026-07-02Read Accumulation24.75-0.1% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Sachem Capital Corp. 6.00% Note holds its Markdown at $24.72. The statistical read favours the buyers, held for 203 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 203 days |
| Price at the screen | $24.72 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Sachem Capital Corp. 6.00% Note clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
We do not yet have the financial statements needed to run the debt, cash, receivables and income screens for Sachem Capital Corp. 6.00% Note, so it is not scored yet.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
Where & How to TradeSCCE trades on NYSE American. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-02
Markdown · changed $24.72
-0.1% Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 7%.
2026-09-12
Accumulation · changed $24.75
+0.0% Entry 5
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 7%.
2026-08-12
Markdown · changed $24.75
+0.0% Entry 4
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 7%.
2026-07-18
Accumulation $24.75
+0.0% Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 7%.
2026-07-03
Accumulation $24.75
+0.0% Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02
Accumulation $24.75
Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $24.00 | +3.0% | · | $1,030 | +3.0% |
| 2 months | $24.02 | +2.9% | · | $1,029 | +2.9% |
| 3 months | $23.75 | +4.1% | · | $1,041 | +4.1% |
| 6 months | $22.91 | +7.9% | $0.38 | $1,095 | +9.5% |
| 1 year | $18.31 | +35.0% | $0.75 | $1,391 | +39.1% |
| 2 years | $20.09 | +23.1% | $1.88 | $1,324 | +32.4% |
| 3 years | $17.76 | +39.2% | $3.38 | $1,581 | +58.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SCCE does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.